Physician

Laura Mathis Burdick, MD

According to 2025 Medicare claims, Laura Burdick, MD (NPI: 1205028164) practices dermatology in the Columbus, IN market, with the plurality of this provider's patient population coming from Bartholomew, IN. This provider's primary affiliated billing organization is DERMATOLOGY PHYSICIANS, INC. (NPI: 1932135241; TIN: 351178212) and primary practice location at 47201-2902.

Burdick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 685 traditional Medicare patients, billed 4,725 HCPCS/CPT codes, and received $193,243 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 915 prescription claims across 380 beneficiaries totaling $221,389 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 10 records totaling $272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $38,659 and ending at $221,389. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$101K$203K2015 Medicare payment: $154,159 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $164,871 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $187,851 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $202,878 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $191,748 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $156,777 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $198,590 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $183,022 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $187,919 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $193,243 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156133,833$154,159
20167564,275$164,871
20178165,289$187,851
20188075,545$202,878
20197845,236$191,748
20206864,225$156,777
20216414,777$198,590
20226374,842$183,022
20236535,019$187,919
20246854,725$193,243

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$111K$221K2015 Drug cost: $38,659 (USD; Tot_Drug_Cst)2016 Drug cost: $28,357 (USD; Tot_Drug_Cst)2017 Drug cost: $37,648 (USD; Tot_Drug_Cst)2018 Drug cost: $33,004 (USD; Tot_Drug_Cst)2019 Drug cost: $59,698 (USD; Tot_Drug_Cst)2020 Drug cost: $43,977 (USD; Tot_Drug_Cst)2021 Drug cost: $32,524 (USD; Tot_Drug_Cst)2022 Drug cost: $19,303 (USD; Tot_Drug_Cst)2023 Drug cost: $21,640 (USD; Tot_Drug_Cst)2024 Drug cost: $221,389 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015276553$38,659
2016286562$28,357
2017355808$37,648
2018365843$33,004
2019309683$59,698
2020266563$43,977
2021314734$32,524
2022289653$19,303
2023337831$21,640
2024380915$221,389

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths245343$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more502741$61
11102Biopsy of related skin growth, first growth279379$57
17000Destruction of precancer skin growth, 1 growth407583$30
17003Destruction of precancer skin growth, 2-14 growths2801,671$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab15420$57,434
Clobetasol PropionateClobetasol Propionate1012,828$5,663
Triamcinolone AcetonideTriamcinolone Acetonide3209,087$1,848
FluorouracilFluorouracil26729$1,813
MetronidazoleMetronidazole331,109$1,595

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$272ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Laura Mathis Burdick, MD?

Tedicare shows public-source Medicare data for Laura Mathis Burdick, MD (NPI 1205028164), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Mathis Burdick, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura Mathis Burdick, MD?

Laura Mathis Burdick, MD is linked to DERMATOLOGY PHYSICIANS, INC. (billing NPI 1932135241) in the available physician profile data.

Does Laura Mathis Burdick, MD have Open Payments data?

Laura Mathis Burdick, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.